News

Cindy Yu talks to Mark Kotter about cultured meat and its possible impact on sustainability.

The piece covers potential treatments for dementia and muscular dystrophy with engineered human cells.

bit.bio CEO and founder Dr Mark Kotter was a speaker on the podcast Danny in the Valley.

Featured on Massive Science: how bit.bio's breakthrough opti-ox™ technology is being used by cultured meat company Meatable.

bit.bio wins Biotech Company of the Year at the Cambridge Independent Science andTechnology awards.

SynbioBeta CEO John Cumbers talks reimagining cell therapies through cell reprogramming with Rick Klausner and bit.bio CEO.

Dr Farah Patell-Socha, VP of Research Products discusses the launch of ioSkeletal Myocytes.

IBI Journal Q&A with Dr Mark Kotter who talks about producing every human cell type at scale.